Sheldon H. Rubin
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
-
- CNS Lymphoma Diagnosis and Treatment 2
- Co-authors
- Dongsheng Tu (2 shared papers)Julie R. Gralow (1 shared paper)Keren B. Sturtz (1 shared paper)Hyman Bernard Muss (1 shared paper)Eric P. Winer (1 shared paper)Kathleen Pritchard (1 shared paper)Joseph Thaddeus Beck (1 shared paper)Karen A. Gelmon (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (3 papers)Leukemia Research (1 paper)Bone Marrow Transplantation (1 paper)Canadian Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Sheldon H. Rubin
16 papers receiving 1.1k citations
Sheldon H. Rubin's Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 268
- Oncology 496
- Cancer Research 270
- Family Practice 21
- Pulmonary and Respiratory Medicine 202
Countries citing papers authored by Sheldon H. Rubin
This map shows the geographic impact of Sheldon H. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon H. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon H. Rubin more than expected).
Fields of papers citing papers by Sheldon H. Rubin
This network shows the impact of papers produced by Sheldon H. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon H. Rubin. The network helps show where Sheldon H. Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon H. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Hit paper breakdown → | 2016 | 499 |
| 2 | 2002 | 217 | |
| 3 | 1976 | 86 | |
| 4 | 1995 | 81 | |
| 5 | 2006 | 68 | |
| 6 | 1995 | 49 | |
| 7 | 2012 | 42 | |
| 8 | 2011 | 28 | |
| 9 | 2007 | 19 | |
| 10 | 2000 | 16 | |
| 11 | 1999 | 7 | |
| 12 | 2009 | 4 | |
| 13 | 2009 | 4 | |
| 14 | 2007 | 3 | |
| 15 | 2008 | 3 | |
| 16 | 1987 | 1 |
About Sheldon H. Rubin
Sheldon H. Rubin is a scholar working on Hematology, Neurology, Oncology, Pathology and Forensic Medicine and Hepatology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Ubiquitin and proteasome pathways (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (268 citations), Oncology (496 citations), Cancer Research (270 citations), Family Practice (21 citations) and Pulmonary and Respiratory Medicine (202 citations). Sheldon H. Rubin has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Dongsheng Tu, Julie R. Gralow, Keren B. Sturtz, Hyman Bernard Muss, Eric P. Winer, Kathleen Pritchard, Joseph Thaddeus Beck, Karen A. Gelmon, Antonio C. Wolff and Kate Whelan. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Bone Marrow Transplantation and Canadian Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.